MAP2K7 and colorectal carcinoma: Treatment of CRC cell lines with the MEK inhibitor U0126 significantly reduced the proliferation of RAF1 proficient spheroids and further reduced spheroid size in RAF1 KO DLD1, SW1116 and KM12 (Fig. 3C).